Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AADPAC, Abbott, abstention, ACALIX, Advisory, Anesthetic, attenuate, began, Biberstein, CARDIZEM, category, CD, Committee, CR, demand, deteriorate, device, diligence, DILTELAN, DILZEM, DINISOR, Ehrich, Elliott, FOCALIN, fundamental, GA, greatest, healthy, Heterocyclic, hypothetical, infrastructure, introduction, Kathryn, Landine, large, lauroxil, licensee, line, Meloxicam, Michael, mid, month, monthly, Neurological, NV, olanzapine, peer, pen, physical, Prepaid, prescribed, promissory, Psychological, scope, side, size, spent, SR, TILAZEM, USPTO, version, vetted, vote, voted, weekly, widely, XL, ZYPREXA
Removed:
cocaine, diversify, invest, marketing, pursue, quantity, reduce, VERELAN
Filing tables
Filing exhibits
Related press release
ALKS similar filings
Filing view
External links